A randomized controlled trial investigating the effect of Pycnogenol and BacopaCDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910)
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: One of the major challenges associated with our ageing population is the increasing incidence of age-associated cognitive decline, which has significant implications for an individual's ability to lead a productive and fulfilling life. In pure economic terms the costs of ageing reflects decreased productivity and engagement with the workforce. The maintenance of brain health underpinning intact cognition is a key factor to maintaining a positive, engaged, and productive lifestyle. In light of this, the role of diet, including supplementation with nutritional and even pharmacological interventions capable of ameliorating the neurocognitive changes that occur with age constitute vital areas of research. METHODS: In order to reduce cognitive ageing, the ARC longevity intervention (ARCLI) was developed to examine the effects of two promising natural pharmacologically active supplements on cognitive performance. ARCLI is a randomized, placebo-controlled, double-blind, 3-arm clinical trial in which 465 participants will be randomized to receive an extract of Bacopa monnieri (CDRI08 300 mg/day), Pycnogenol (150 mg/day), or placebo daily for 12 months. Participants will be tested at baseline and then at 3, 6 and 12 months post-randomization on a wide battery of cognitive, neuropsychological and mood measures, cardiovascular (brachial and aortic systolic and diastolic blood pressures as well as arterial stiffness), biochemical (assays to measure inflammation, oxidative stress and safety) as well as genetic assessments (telomere length and several Single Nucleotide Polymorphisms). The primary aim is to investigate the effects of these supplements on cognitive performance. The secondary aims are to explore the time-course of cognitive enhancement as well as potential cardiovascular and biochemical mechanisms underpinning cognitive enhancement over the 12 months of administration.ARCLI will represent one of the largest and most comprehensive experimental clinical trials in which supplements are administered to elderly participants. Results from ARCLI may help develop novel preventative health practices and nutritional/pharmacological targets in the elderly for cognitive and brain health. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12611000487910.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
Vlachopoulos, C., Aznaouridis, K., & Stefanadis, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.061 · Cited by 4,165 · cited 1×
“Brachial pressures, aortic pressures and carotid-femoral Pulse Wave Velocity (PWV) are not only associated with cardiovascular disease risk and mortality [59,60] but also cognitive performance and decline [61,62].”
BackgroundDevelopment of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032 · cited 1×
“Throughout the trial, general health, fatigue and sleep quality will be assessed with the General Health Questionnaire [56], Chalder Fatigue Scale [57] and the Leeds Sleep Evaluation Questionnaire [58] respectively.”
MethodA Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 1×
“[14]).”
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Vlachopoulos, C., Aznaouridis, K., O'Rourke, M. F., Safar, M. E., Baou, K., & Stefanadis, C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq024 · Cited by 1,363 · cited 1×
“Brachial pressures, aortic pressures and carotid-femoral Pulse Wave Velocity (PWV) are not only associated with cardiovascular disease risk and mortality [59,60] but also cognitive performance and decline [61,62].”
BackgroundExcess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296 · cited 1×
“Concurrent with the normal age-related cognitive changes are increases in the formation of brain ROS resulting in significant damage to DNA, proteins and in particular membrane lipids [13].”
BackgroundPacker, L., Rimbach, G., & Virgili, F. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00090-8 · Cited by 660 · cited 1×
“Extensive reviews by Packer et al [19] and Rohdewald [20] have established the antioxidant activity of Pycnogenol in simplified assay systems, cultured cell models, and perfused organs.”
BackgroundBacopa monniera, a reputed nootropic plant: An overview
Russo, A., & Borrelli, F. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.12.008 · Cited by 447 · cited 1×
“Bacopa monniera Hayata & Matsum) has been used in traditional Ayurvedic medicine for various indications including memory decline, inflammation, pain, pyrexia, epilepsy and as a sedative [29].”
MethodC., S., P., N., J., L., J., C., C., H., L., D., & T., R. (2001) · Psychopharmacology · doi:10.1007/s002130100815 · Cited by 342
Research works printed but not linked: 54
- Christensen H, Kumar R: Cognitive Changes and the Ageing Brain. The Ageing Brain. Edited by: Sachdev PS. 2003, Lisse: Swets & Zeitlinger, B.V, 75-96.
- Looi J, Sachdev PS: Structural Neuroimaging of the Ageing Brain. The Ageing Brain. Edited by: Sachdev PS. 2003, Lisse: Swets & Zeitlinger, 49-62.
- MacLullich AMJ, Ferguson KJ, Deary IJ, Seckl JR, Starr JM, Wardlaw JM: Intracranial capacity and brain volumes are associated with cognition in healthy elderly men. Neurology. 2002, 59 (2): 169-174. · DOI · Paper page
- Slater TF: Free-radical mechanisms in tissue injury. Biochemical Journal. 1984, 222 (1): 1-15. · DOI · Paper page
- Packer L: Free radical scavengers and antioxidants in prophylaxy and treatment of brain diseases. Free Radicals in the Brain. Edited by: Packer L, Prilipko L, Christen Y. New York. 1992, Springer-Verlag · DOI
- Papa S, Skulachev VP: Reactive oxygen species, mitochondria, apoptosis and aging. Molecular and Cellular Biochemistry. 1997, 174 (1-2): 305-319. · DOI · Paper page
- Artur Y, Herbeth B, Guémouri L, Lecomte E, Jeandel C, Siest G: Age-related variations of enzymatic defenses against free radicals and peroxides. EXS. 1992, 62: 359-367.
- Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993, 262 (5134): 689-695. 10.1126/science.7901908. · DOI · Paper page
- Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N: Oxidative damage in Alzheimer's [6]. Nature. 1996, 382 (6587): 120-121. · DOI · Paper page
- Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS: Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proceedings of the National Academy of Sciences of the USA. 1996, 93 (10): 4765-4769. 10.1073/pnas.93.10.4765. · DOI · Paper page
- Socci DJ, Crandall BM, Arendash GW: Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Research. 1995, 693 (1-2): 88-94. 10.1016/0006-8993(95)00707-W. · DOI · Paper page
- Goodwin JS, Goodwin JM, Garry PJ: Association between nutritional status and cognitive functioning in a healthy elderly population. Journal of the American Medical Association. 1983, 249 (21): 2917-2921. 10.1001/jama.1983.03330450047024. · DOI · Paper page
- Masaki KH, Losonczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik R, White LR: Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000, 54 (6): 1265-1272. · DOI · Paper page
- Srám RJ, Binková B, Topinka J, Kotěsovec F, Fojtíková I, Hanel I, Klaschka J, Kocisóvá J, Prosek M, Machálek J: Effect of antioxidant supplementation in an elderly population. Basic life sciences. 1993, 61: 459-477.
- Rohdewald P: A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology. International Journal of Clinical Pharmacology and Therapeutics. 2002, 40 (4): 158-168. · DOI · Paper page
- Wei ZH, Peng QL, Lau BHS: Pycnogenol enhances endothelial cell antioxidant defenses. Redox Report. 1997, 3 (4): 219-224. · DOI · Paper page
- Ishige K, Schubert D, Sagara Y: Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Biology and Medicine. 2001, 30 (4): 433-446. 10.1016/S0891-5849(00)00498-6. · DOI · Paper page
- Kobayashi MS, Han D, Packer L: Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity. Free Radical Research. 2000, 32 (2): 115-124. 10.1080/10715760000300121. · DOI
- Liu F, Lau BHS, Peng Q, Shah V: Pycnogenol protects vascular endothelial cells from α-amyloid-induced injury. Biological and Pharmaceutical Bulletin. 2000, 23 (6): 735-737. 10.1248/bpb.23.735. · DOI
- Peng QL, Buz'Zard AR, Lau BHS: Pycnogenol® protects neurons from amyloid-β peptide-induced apoptosis. Molecular Brain Research. 2002, 104 (1-2): 55-65. · DOI
- Liu FJ, Zhang YX, Lau BHS: Pycnogenol enhances immune and haemopoietic functions in senescence-accelerated mice. Cellular and Molecular Life Sciences. 1998, 54 (10): 1168-1172. 10.1007/s000180050245. · DOI
- Devaraj S, Vega-López S, Kaul N, Schönlau F, Rohdewald P, Jialal I: Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids. 2002, 37 (10): 931-934. 10.1007/s11745-006-0982-3. · DOI · Paper page
- Prior RL, Cao G: In vivo total antioxidant capacity: Comparison of different analytical methods. Free Radical Biology and Medicine. 1999, 27 (11-12): 1173-1181. 10.1016/S0891-5849(99)00203-8. · DOI · Paper page
- Singh HK, Dharwan BN: Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera linn (Brahmi). Indian Journal of Pharmacology. 1997, 29: S359-S365.
- Agrawal A: A comparative study of psychotropic drugs and bio-feedback therapy in the prevention and management of psychosomatic disorder. Thesis. 1993, Varanasi: Banaras Hindu University
- Bhattacharya SK, Kumar A, Ghosal S: Effect of Bacopa monniera on animal models of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. Research Communications in Pharmacology and Toxicology. 1999, 4 (3&4): 1-12.
- Jain SK: Ethnobotany and research on medicinal plants in India. Ciba Found Symp. 1994, 185: 153-164. discussion 164-158
- Bhattacharya S, Ghosal S: Anxiolytic activity of a standardized extract of Bacopa monniera: an experimental study. Phytomedicine. 1998, 5 (2): 77-82. 10.1016/S0944-7113(98)80001-9. · DOI
- Sairam K, Dorababu M, Goel RK, Bhattacharya SK: Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine. 2002, 9 (3): 207-211. 10.1078/0944-7113-00116. · DOI · Paper page
- Dar A, Channa S: Calcium antagonistic activity of Bacopa monniera on vascular and intestinal smooth muscles of rabbit and guinea-pig. J Ethnopharmacol. 1999, 66 (2): 167-174. 10.1016/S0378-8741(98)00240-2. · DOI
- Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh HK: Adaptogenic effect of Bacopa monniera (Brahmi). Pharmacol Biochem Behav. 2003, 75 (4): 823-830. 10.1016/S0091-3057(03)00156-4. · DOI
- Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S: Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res. 2000, 14 (3): 174-179. 10.1002/(SICI)1099-1573(200005)14:3<174::AID-PTR624>3.0.CO;2-O. · doi:10.1002/(sici)1099-1573(200005)14:3<174::aid-ptr624>3.0.co;2-o
- Russo A, Borrelli F, Campisi A, Acquaviva R, Raciti G, Vanella A: Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera. Life Sci. 2003, 73 (12): 1517-1526. 10.1016/S0024-3205(03)00476-4. · DOI
- Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP: Bacopa monniera Linn. as an antioxidant: mechanism of action. Indian J Exp Biol. 1996, 34 (6): 523-526.
- Ryan J, Croft K, Mori T, Wesnes K, Spong J, Downey L, Kure C, Lloyd J, Stough C: An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. Journal of Psychopharmacology. 2008, 22 (5): 553-562. 10.1177/0269881108091584. · DOI · Paper page
- Pipingas A, Harris E, Tournier E, King R, Kras M, Stough CK: Assessing the efficacy of nutraceutical interventions on cognitive functioning in the elderly. Current Topics in Nutraceutical Research. 2010, 8 (2-3): 79-87.
- Pipingas A, Silberstein RB, Vitetta L, Van Rooy C, Harris EV, Young JM, Frampton CM, Sali A, Nastasi J: Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract formulation. Phytotherapy Research. 2008, 22 (9): 1168-1174. 10.1002/ptr.2388. · DOI
- Scholey AB, French SJ, Morris PJ, Kennedy DO, Milne AL, Haskell CF: Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. Journal of Psychopharmacology. 2010, 24 (10): 1505-1514. 10.1177/0269881109106923. · DOI · Paper page
- Folstein MF, Folstein SE, McHugh PR: 'Mini mental state'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975, 12 (3): 189-198. 10.1016/0022-3956(75)90026-6. · DOI · Paper page
- Deary IJ, Stough C: Intelligence and Inspection Time: Achievements, Prospects, and Problems. American Psychologist. 1996, 51 (6): 599-608. · doi:10.1037/0003-066x.51.6.599 · Paper page
- Jensen AR: The theory of intelligence and its measurement. Intelligence. 2011, 39 (4): 171-177. 10.1016/j.intell.2011.03.004. · DOI
- Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Archives of general psychiatry. 1961, 4: 561-571. 10.1001/archpsyc.1961.01710120031004. · DOI · Paper page
- Spielberger CD, Gorsuch RL, Lushene RE: Manual for the State-Trait Anxiety Inventory. Palo Alto. 1970, California: Consulting Psychologists Press
- McNair DM, Lorr M, Droppelman LM: Profile of Mood States. 1970, San Diego: Educational and Industrial Testing Service
- Goldberg D: General Health Questionnaire (GHQ-12). 1992, Windsor, England: NFER-Nelson
- Parrott AC, Hindmarch I: Factor analysis of a sleep evaluation questionnaire. Psychological Medicine. 1978, 8 (2): 325-329. 10.1017/S0033291700014379. · DOI · Paper page
- Pase MP, Pipingas A, Kras M, Nolidin K, Gibbs AL, Wesnes KA, Scholey AB, Stough C: Healthy middle-aged individuals are vulnerable to cognitive deficits as a result of increased arterial stiffness. Journal of Hypertension. 2010, 28 (8): 1724-1729. 10.1097/HJH.0b013e32833b1ee7. · DOI · Paper page
- Pase MP, Herbert A, Grima NA, Pipingas A, O' Rourke MF: Arterial stiffness as a cause of cognitive decline and dementia: A systematic review and meta-analysis. Internal Medicine Journal.
- Pase MP, Grima NA, Sarris J: The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. American Journal of Clinical Nutrition. 2011, 93 (446-454): · DOI · Paper page
- Tanaka H, Safar ME: Influence of lifestyle modification on arterial stiffness and wave reflections. American Journal of Hypertension. 2005, 18 (1): 137-144. 10.1016/j.amjhyper.2004.07.008. · DOI · Paper page
- Pase MP, Grima NA, Sarris J: Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials. British Journal of Nutrition. 2011, 106 (07): 974-980. 10.1017/S0007114511002819. · DOI · Paper page
- Messier C, Tsiakas M, Gagnon M, Desrochers A, Awad N: Effect of age and glucoregulation on cognitive performance. Neurobiology of Aging. 2003, 24 (7): 985-1003. 10.1016/S0197-4580(03)00004-6. · DOI
- Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993, 43 (8): 1467-1472. · DOI · Paper page
- Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JWR, Van Kamp GJ, Deeg DJH: Memory complaints and APOE-ε4 accelerate cognitive decline in cognitively normal elderly. Neurology. 2001, 57 (12): 2217-2222. · DOI · Paper page
Cited by
Andrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vellas, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00153-2 · Cited by 293
Traditional medicines and globalization: current and future perspectives in ethnopharmacology
Leonti, M., & Casu, L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00092 · Cited by 272
Benson, S., Downey, L. A., Stough, C., Wetherell, M., Zangara, A., & Scholey, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5029 · Cited by 97
Self-citationDowney, L. A., Kean, J., Nemeh, F., Lau, A., Poll, A., Gregory, R., Murray, M., Rourke, J., Patak, B., Pase, M. P., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.4864 · Cited by 70
“…of randomized controlled trials in healthy middle-aged to elderly adults have demonstrated that consumption of standardized extracts of BM can improve components of human cognition (Calabrese et al., 2008; Morgan and Stevens, 2010; Stough et al., 2008; Stough et al., 2001; Stough et al., 2012).”
BackgroundSelf-citationInhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents
Ramasamy, S., Kiew, L., & Chung, L. (2014) · Molecules · doi:10.3390/molecules19022588 · Cited by 47
“monnieri extract dose of 300 mg/day [2–4,26] and an intestinal volume of approximately 500 mL may result in an estimated B.”
BackgroundMethod
Metadata
- Authors
- Stough, C. K., Pase, M. P., Cropley, V., Myers, S., Nolidin, K., King, R., Camfield, D., Wesnes, K., Pipingas, A., Croft, K., Chang, D., & Scholey, A. B.
- Venue
- Nutrition Journal
- Published
- 2012-03-06
- Volume
- 11
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1475-2891 (ISSN-L)
- OpenAlex
- W2106965256
- Cited by
- 61
- References
- 13
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized controlled trial investigating the effect of Pycnogenol and BacopaCDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910). https://app.cochat.ai/papers/10.1186/1475-2891-11-11
- The paper
- Stough, C. K., Pase, M. P., Cropley, V., Myers, S., Nolidin, K., King, R., Camfield, D., Wesnes, K., Pipingas, A., Croft, K., Chang, D., & Scholey, A. B. (2012). A randomized controlled trial investigating the effect of Pycnogenol and BacopaCDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910). Nutrition Journal. https://doi.org/10.1186/1475-2891-11-11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.